Rekvina Laboratories Ltd. Announces Trading Window Closure
Rekvina Laboratories Ltd. has announced the closure of its trading window for designated individuals and their immediate relatives, effective April 1, 2026. This measure is in accordance with the company's "Code of Fair Disclosure" and the SEBI (Prohibition of Insider Trading) Regulations, 2015.The trading window will remain closed until 48 hours after the company announces its audited financial results for the quarter and year ended March 31, 2026.
The date for the board meeting to review and approve the audited financial results will be communicated at a later time.
Rekvina Laboratories Ltd. is listed on the Bombay Stock Exchange under script code 526075.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.